Trending storyDeveloping
CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults
1 report1 sourceupdated 9 hours ago
Start here
No synthesis yet — start with the coverage timeline below.
Coverage timeline
Follow the coverage to see the different angles.
Oct 16
Heat trend for this story
Not enough continuous observation yet to draw a trend.